---
title: "Sun-Novo: BTP4507 has received the notification of approval for clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260772618.md"
description: "According to the Zhitong Finance APP, Sun-Novo announced that its subsidiary Jiangsu Novo Biotech Co., Ltd. has received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration. The clinical trial application for the company's research project BTP4507 has been approved. BTP4507 is intended for the treatment of patients with primary hypertension who have poor response to monotherapy"
datetime: "2025-10-12T08:34:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260772618.md)
  - [en](https://longbridge.com/en/news/260772618.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260772618.md)
---

# Sun-Novo: BTP4507 has received the notification of approval for clinical trials

According to the Zhitong Finance APP, Sun-Novo (688621.SH) announced that its subsidiary Jiangsu Novo Biotech New Drug Research and Development Co., Ltd. has received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration. The clinical trial application for the company's research project BTP4507 has been approved. BTP4507 is intended for the treatment of patients with primary hypertension who have poor response to monotherapy

### Related Stocks

- [688621.CN](https://longbridge.com/en/quote/688621.CN.md)

## Related News & Research

- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [HAV Group to webcast Q1 2026 results presentation](https://longbridge.com/en/news/287020287.md)
- [Trump signs order aimed at preventing illicit financial activity, White House says](https://longbridge.com/en/news/286970478.md)
- [Saniona hosts Q1 investor call with results and company update webcast](https://longbridge.com/en/news/287014001.md)
- [16:51 ETBeverly Hills MD ProRetinol Age Rewind x3 Officially Launches: A New Era of Gentle, Slow-Released Retinol Skincare Backed by Plastic Surgeons](https://longbridge.com/en/news/286966075.md)